These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
165 related items for PubMed ID: 7037247
1. Immunosuppressive treatment in the prevention of renal failure in primary glomerular diseases. Glassock RJ. Clin Exp Dial Apheresis; 1981; 5(1-2):21-46. PubMed ID: 7037247 [Abstract] [Full Text] [Related]
8. Forms of nephrotic syndrome more likely to progress to renal impairment. Chesney RW, Novello AC. Pediatr Clin North Am; 1987 Jun; 34(3):609-27. PubMed ID: 3295719 [Abstract] [Full Text] [Related]
13. Standard immunosuppressive therapy of immune-mediated glomerular diseases. Pani A. Autoimmun Rev; 2013 Jun 30; 12(8):848-53. PubMed ID: 23219765 [Abstract] [Full Text] [Related]
14. Conventional treatment of idiopathic nephrotic syndrome and membranous nephropathy in adults. Ponticelli C, Passerini P. Clin Nephrol; 1991 Jun 30; 35 Suppl 1():S16-21. PubMed ID: 1860261 [Abstract] [Full Text] [Related]
15. Immunosuppressive therapy in primary glomerulonephritis (pros). Ponticelli C, Banfi G, Imbasciati E, Tarantino A. Contrib Nephrol; 1982 Jun 30; (34):33-54. PubMed ID: 6293765 [No Abstract] [Full Text] [Related]
16. Successful mycophenolate mofetil treatment of glomerular disease. Briggs WA, Choi MJ, Scheel PJ. Am J Kidney Dis; 1998 Feb 30; 31(2):213-7. PubMed ID: 9469489 [Abstract] [Full Text] [Related]
18. Combined immunosuppressive therapy in steroid-resistant, chronic glomerular diseases of childhood. Campbell RA, Jacinto EY. J Lancet; 1967 May 30; 87(5):149-56 passim. PubMed ID: 6043891 [No Abstract] [Full Text] [Related]
19. Mycophenolate mofetil in primary glomerulopathies. Sepe V, Libetta C, Giuliano MG, Adamo G, Dal Canton A. Kidney Int; 2008 Jan 30; 73(2):154-62. PubMed ID: 17989649 [Abstract] [Full Text] [Related]
20. Treatment of corticoresistant idiopathic nephrotic syndrome in the adult: minimal change disease and focal segmental glomerulosclerosis. Meyrier A, Simon P. Adv Nephrol Necker Hosp; 1988 Jan 30; 17():127-50. PubMed ID: 3124536 [Abstract] [Full Text] [Related] Page: [Next] [New Search]